Articoli con mandati relativi all'accesso pubblico - Moherndran ArcharyUlteriori informazioni
Non disponibili pubblicamente: 3
Bacterial infections in HIV-infected children admitted with severe acute malnutrition in Durban, South Africa
M Archary, H Adler, P La Russa, P Mahabeer, RA Bobat
Paediatrics and International Child Health 37 (1), 6-13, 2017
Mandati: US National Institutes of Health
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the …
A Turkova, MK Chan, C Kityo, AR Kekitiinwa, P Musoke, A Violari, ...
Contemporary Clinical Trials 142, 107540, 2024
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Serum cryptococcal antigen testing in immunosuppressed HIV-positive children and adolescents
P Zuma, Y Ramsamy, K Mlisana, M Archary
The Pediatric Infectious Disease Journal 39 (3), 217-220, 2020
Mandati: US National Institutes of Health
Disponibili pubblicamente: 55
Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ...
New England Journal of Medicine 384 (20), 1899-1909, 2021
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health
Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave
BC Zanoni, M Archary, S Buchan, IT Katz, JE Haberer
BMJ global health 1 (3), e000004, 2016
Mandati: US National Institutes of Health
Dolutegravir as first-or second-line treatment for HIV-1 infection in children
A Turkova, E White, HA Mujuru, AR Kekitiinwa, CM Kityo, A Violari, ...
New England Journal of Medicine 385 (27), 2531-2543, 2021
Mandati: National Institute of Health and Medical Research, France, UK Medical …
Nevirapine-versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial
L Barlow-Mosha, K Angelidou, J Lindsey, M Archary, M Cotton, S Dittmer, ...
Clinical Infectious Diseases 63 (8), 1113-1121, 2016
Mandati: US National Institutes of Health
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
JN Bhiman, SI Richardson, BE Lambson, P Kgagudi, N Mzindle, ...
Scientific reports 13 (1), 1222, 2023
Mandati: Bill & Melinda Gates Foundation, National Research Foundation, South Africa
Malnutrition in HIV-infected children is an indicator of severe disease with an impaired response to antiretroviral therapy
M Muenchhoff, M Healy, R Singh, J Roider, A Groll, C Kindra, T Sibaya, ...
AIDS research and human retroviruses 34 (1), 46-55, 2018
Mandati: US National Institutes of Health, Wellcome Trust, Doris Duke Charitable …
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A …
SA Madhi, D Moodley, S Hanley, M Archary, Z Hoosain, U Lalloo, C Louw, ...
The Lancet HIV 9 (5), e309-e322, 2022
Mandati: Bill & Melinda Gates Foundation
Long-acting antiretrovirals and HIV treatment adherence
JB Nachega, KK Scarsi, M Gandhi, RK Scott, LM Mofenson, M Archary, ...
The Lancet HIV 10 (5), e332-e342, 2023
Mandati: US National Institutes of Health
Transition from pediatric to adult care for adolescents living with HIV in South Africa: A natural experiment and survival analysis
BC Zanoni, M Archary, T Sibaya, N Musinguzi, JE Haberer
PLoS One 15 (10), e0240918, 2020
Mandati: US National Institutes of Health
High-frequency failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal non-adherence
JR Millar, N Bengu, R Fillis, K Sprenger, V Ntlantsana, VA Vieira, ...
EClinicalMedicine 22, 2020
Mandati: US National Institutes of Health, National Institute for Health Research, UK …
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps …
S Nachman, CL Townsend, EJ Abrams, M Archary, E Capparelli, ...
The Lancet HIV 6 (8), e552-e558, 2019
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health
Systematic review of mHealth interventions for adolescent and young adult HIV prevention and the adolescent HIV continuum of care in low to middle income countries
M Goldstein, M Archary, J Adong, JE Haberer, LM Kuhns, A Kurth, ...
AIDS and Behavior 27 (Suppl 1), 94-115, 2023
Mandati: US National Institutes of Health
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review
TG Jacobs, EM Svensson, V Musiime, P Rojo, KE Dooley, H McIlleron, ...
Journal of Antimicrobial Chemotherapy 75 (12), 3433-3457, 2020
Mandati: UK Medical Research Council
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested …
CL Moore, A Turkova, H Mujuru, A Kekitiinwa, A Lugemwa, CM Kityo, ...
BMC infectious diseases 21, 1-14, 2021
Mandati: National Institute of Health and Medical Research, France, UK Medical …
Disclosure, social support, and mental health are modifiable factors affecting engagement in care of perinatally-HIV infected adolescents: a qualitative dyadic analysis
BC Zanoni, M Archary, T Subramony, T Sibaya, C Psaros, JE Haberer
AIDS and Behavior 25, 237-248, 2021
Mandati: US National Institutes of Health
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label …
TD Ruel, EP Acosta, JP Liu, KP Gray, K George, N Montañez, S Popson, ...
The Lancet HIV 9 (5), e332-e340, 2022
Mandati: US National Institutes of Health
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
P Amuge, A Lugemwa, B Wynne, HA Mujuru, A Violari, CM Kityo, ...
The Lancet HIV 9 (9), e638-e648, 2022
Mandati: US National Institutes of Health, UK Medical Research Council, National …
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software